NEW YORK (GenomeWeb) – NanoCellect Biomedical, a developer of microfluidic cell sorting technologies, announced today that it has completed a $10 million Series B financing round, including convertible notes.

The financing included the participation of existing investors FusionX Ventures and Agilent Technologies, in addition to new investors Illumina Ventures, Anzu Partners, Vertical Venture Partners, and 5 Prime Ventures.    

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.